Indications and Purposes
| 1 Indications And Usage Minivelle® Is An Estrogen Indicated For: Treatment Of Moderate To Severe Vasomotor Symptoms Due To Menopause ( 1.1 ) Prevention Of Postmenopausal Osteoporosis ( 1.2 ) 1.1 Treatment Of Moderate To Severe Vasomotor Symptoms Due To Menopause Minivelle Is Indicated For The Treatment Of Moderate To Severe Vasomotor Symptoms Due To Menopause. 1.2 Prevention Of Postmenopausal Osteoporosis Minivelle Is Indicated For The Prevention Of Postmenopausal Osteoporosis. When Prescribing Solely For The Prevention Of Postmenopausal Osteoporosis, Therapy Should Only Be Considered For Women At Significant Risk Of Osteoporosis And Non-Estrogen Medications Should Be Carefully Considered. Limitation Of Use When Prescribing Solely For The Prevention Of Postmenopausal Osteoporosis, Therapy Should Only Be Considered For Women At Significant Risk Of Osteoporosis And Non-Estrogen Medications Should Be Carefully Considered. |
All Formulated Excipients (0 Total)
None
Active Ingredients ( 1 Total)
| Name | Structure | ZINC ID(s) |
|---|---|---|
| 1. Estradiol |
|
ZINC3881556 |